Zepp Health Corporation
ZEPP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $823 | $75 | $83 | $77 |
| - Cash | $439 | $683 | $754 | $808 |
| + Debt | $785 | $1,387 | $1,349 | $1,329 |
| Enterprise Value | $1,168 | $780 | $677 | $598 |
| Revenue | $540 | $427 | $280 | $433 |
| % Growth | 26.3% | 52.6% | -35.4% | – |
| Gross Profit | $206 | $155 | $104 | $159 |
| % Margin | 38.2% | 36.2% | 37.3% | 36.8% |
| EBITDA | $6 | -$36 | -$130 | -$134 |
| % Margin | 1.2% | -8.5% | -46.5% | -31% |
| Net Income | -$12 | -$56 | -$143 | -$269 |
| % Margin | -2.1% | -13% | -51.2% | -62% |
| EPS Diluted | -4.56 | -14 | -35.76 | -66.96 |
| % Growth | 67.4% | 60.9% | 46.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |